Evidence‑Based Recommendations for the Evaluation of Progressive and Acute Amnestic Syndromes

Progressive Amnestic Syndromes (Chronic/Insidious Onset)

• Alzheimer’s disease typically begins insidiously with a gradual decline in the ability to learn and retain new information (anterograde amnesia). The presentation is characterized by a slow, progressive course. 1
• Memory loss is usually the earliest and most prominent symptom of Alzheimer’s disease, frequently accompanied by executive dysfunction, depressive symptoms, or anxiety. 2
• Diagnostic criteria for Alzheimer’s disease require impairment in at least one additional cognitive domain beyond memory (e.g., language, visuospatial, or executive function). 3
• When the clinical diagnosis of Alzheimer’s disease is uncertain, cerebrospinal‑fluid analysis showing decreased Aβ42 and increased total‑tau/p‑tau, or amyloid PET imaging, should be considered. 4

Other Neurodegenerative Causes of Progressive Amnesia

• Hippocampal sclerosis, argyrophilic grain disease, primary age‑related tauopathy (PART), and TDP‑43 proteinopathy/LATE can manifest as progressive amnestic disorders. 4
• Dementia with Lewy bodies often presents with fluctuating cognition, visual hallucinations, parkinsonism, and REM‑sleep behavior disorder together with memory impairment. 1
• Frontotemporal lobar degeneration rarely produces isolated amnesia but may be associated with prominent behavioral or executive changes alongside memory complaints. 1

Vascular Cognitive Impairment

• Strategic infarcts that involve memory‑related circuits (e.g., thalamus, hippocampus) can cause a progressive amnestic picture consistent with pure vascular cognitive impairment. 1
• A history of stroke that temporally precedes cognitive decline, the presence of multiple infarcts, or extensive white‑matter disease strongly suggests a vascular etiology for progressive amnesia. 3

Mixed Pathologies in Older Adults

• In individuals older than 85 years, Alzheimer’s pathology frequently co‑exists with cerebrovascular disease, Lewy‑body disease, or a combination of these pathologies (AD + VCID + LBD). 1

Acute/Subacute Amnestic Syndromes – Clinical Decision Points

• Insidious onset with gradual progression should prompt evaluation for Alzheimer’s disease or other neurodegenerative disorders. [1][3]
• Predominant anterograde amnesia may be seen in Alzheimer’s disease, transient global amnesia, Wernicke‑Korsakoff syndrome, or focal hippocampal lesions. [1][3]
• Fluctuating cognition, visual hallucinations, and parkinsonism point toward dementia with Lewy bodies. 1
• Behavioral or personality changes suggest frontotemporal dementia. 3
• Vascular risk factors, a prior stroke, or imaging evidence of infarcts support a diagnosis of vascular cognitive impairment. [1][3]

Recommended Diagnostic Testing

• CSF biomarker analysis (Aβ42, total‑tau, phosphorylated‑tau) is advised when the diagnosis of Alzheimer’s disease remains uncertain after clinical assessment. 4
• FDG‑PET should be employed when structural imaging and clinical evaluation do not yield a definitive diagnosis. 4
• Amyloid PET imaging is appropriate for atypical presentations that require biomarker confirmation, but it should be ordered only after specialist consultation because a positive scan does not confirm Alzheimer’s disease as the sole cause. 4

All statements are supported by the cited literature; the level of evidence was not explicitly graded in the source material.

Causes of Amnestic Disorder

Disease Characteristics

• The American Academy of Neurology suggests that Alzheimer's disease is the most common cause of amnestic disorder, accounting for 50-70% of all dementia cases, with amnestic presentation being its most characteristic clinical manifestation 5, 6
• The prevalence of Alzheimer's disease as a cause of dementia ranges from 50-70% of all diagnosed cases, surpassing other etiologies 5, 6, 7
• The International Association of Gerontology and Geriatrics notes that dementia with Lewy bodies and vascular dementia represent the next most frequent causes after Alzheimer's, although with lower prevalence 8
• The European Federation of Neurological Societies states that Lewy body disorders (Parkinson's disease and dementia with Lewy bodies) along with frontotemporal dementia constitute approximately 8% of patients referred to memory clinics 8
• The American College of Physicians indicates that no more than 1.5% of mild to moderate dementia cases are completely reversible, often due to conditions such as hypothyroidism or vitamin B12 deficiency 8
• The National Institute of Neurological Disorders and Stroke recommends evaluating the temporal pattern of symptom onset, with insidious onset and gradual progression suggesting Alzheimer's disease, while sudden onset suggests vascular or transient causes 9
• The American Academy of Neurology suggests that identifying accompanying symptoms, such as deterioration in multiple cognitive domains, fluctuations, hallucinations, and parkinsonism, can help differentiate between Alzheimer's disease and other dementias 9, 10
• The Alzheimer's Association notes that considering biomarkers, such as reduced Aβ42 and elevated tau and p-tau levels in cerebrospinal fluid, can increase diagnostic certainty of Alzheimer's disease when the diagnosis is uncertain 5, 6
• The American Geriatrics Society warns that in individuals over 85 years old, it is highly likely that multiple etiologies are present, particularly the combination of Alzheimer's pathology with cerebrovascular disease, and therefore, one should not assume a single cause in this age group 10

Amnestic Disorders and Memory Impairment

Core Memory Deficit in Amnestic Disorders

• The American Academy of Neurology defines the amnestic presentation as impairment in learning and recall of recently learned information, which represents the most common syndromic presentation of Alzheimer's disease dementia 11, 12, 13
• Recent memory deficits manifest as difficulty encoding and retrieving new information, with this impairment being the initial and most prominent cognitive feature in the vast majority of individuals with symptomatic Alzheimer's disease 14, 15
• The routine clinical diagnosis of symptomatic Alzheimer's disease should be based on the presence of amnestic deficits, specifically impairment in learning and recall of recently learned information 15